Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,643 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants

NCT05896761

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
  • GSK Investigational Site Ft. Pierce, Florida, United States
  • GSK Investigational Site Sarasota, Florida, United States
View all 32 locations
View Trial Details
Completed

A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children

NCT05197075

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Rahima Moosa Mother and Child Hospital, University of Witwatersrand Johannesburg, South Africa
  • Global Clinical Trials PE Pretoria, South Africa
  • Hosp. Gral. Univ. Gregorio Maranon Madrid, Spain
View Trial Details
Completed

Anti-HIV Medications for People Recently Infected With HIV

NCT00106171

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of British Columbia Vancouver, British Columbia, Canada
  • Sunnybrook Health Sciences Ctr. Toronto, Ontario, Canada
  • Canadian Immunodeficiency Research Collaborative (CIRC) Inc. Toronto, Ontario, Canada
View Trial Details

Related conditions